Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Lilly reports OASIS-2 data with mirikizumab in moderate to severe plaque psoriasis

July 17, 2020

Arcutis begins phase IIb portion of phase I/IIb study of ARQ-252 for chronic hand eczema

July 14, 2020

Kymera and Sanofi partner on IRAK4 protein degraders in inflammation and immunology

July 10, 2020

InMed begins second phase I trial of INM-755 for epidermolysis bullosa

July 8, 2020

Cabaletta opens enrollment in phase I study of DSG3-CAART in mucosal-dominant pemphigus vulgaris

July 7, 2020

New phase II trial evaluates CBP-201 for moderate to severe atopic dermatitis

July 6, 2020

Akeso begins first-in-human study of AK-120 for atopic dermatitis

July 2, 2020

Amniox begins first phase III trial of TTAX-01 in diabetic foot ulcers

July 1, 2020

Ilumya approved in Japan for plaque psoriasis

July 1, 2020

FDA approves IND for SFA-002 study in psoriasis

July 1, 2020

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...